Pneumocystis Pneumonia Severity Is Associated with Taxonomic Shifts in the Respiratory Microbiota

Valentina Del Prete1, Antonia Piazzesi2, Matteo Scanu2

  • 1Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

PubMed

Insights

Pneumocystis pneumonia (PCP) severity is linked to respiratory tract bacteria. Severe PCP shows lower diversity, increased Prevotella, and decreased Neisseria, impacting inflammation and antimicrobial pathways.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonology

Background:

  • Pneumocystis pneumonia (PCP) is a severe infection, especially in immunocompromised individuals.
  • Increasing PCP incidence necessitates understanding factors driving disease severity.
  • The respiratory tract microbiota's role in pulmonary inflammation and pneumonia progression is increasingly recognized.

Purpose of the Study:

  • To investigate the association between respiratory microbiota composition and PCP severity.
  • To identify specific microbial shifts correlating with mild-moderate versus severe PCP cases.

Main Methods:

  • 16S rRNA metataxonomic sequencing was used to profile the respiratory microbiota.
  • Samples were collected from the upper and lower airways of patients with varying PCP severity.
  • Bioinformatic analysis was performed to compare microbial profiles and associated functions.

Main Results:

  • PCP patients exhibited pro-inflammatory bacterial profiles in their airways.
  • Severe PCP was characterized by reduced bacterial diversity.
  • Significant shifts included an increase in Prevotella and a decrease in Neisseria in severe cases.
  • Metabolic pathways related to anti-inflammatory and antimicrobial molecules were decreased in severe PCP.

Conclusions:

  • This study is the first to link respiratory microbiome alterations with PCP severity.
  • Specific microbial signatures may indicate susceptibility to severe PCP manifestations.
  • Understanding these microbiome shifts could inform future therapeutic strategies for PCP.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
211
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
153
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220